Cargando…
Lanthionine Synthetase C-Like 2 Modulates Immune Responses to Influenza Virus Infection
Broad-based, host-targeted therapeutics have the potential to ameliorate viral infections without inducing antiviral resistance. We identified lanthionine synthetase C-like 2 (LANCL2) as a new therapeutic target for immunoinflammatory diseases. To examine the therapeutic efficacy of oral NSC61610 ad...
Autores principales: | Leber, Andrew, Bassaganya-Riera, Josep, Tubau-Juni, Nuria, Zoccoli-Rodriguez, Victoria, Lu, Pinyi, Godfrey, Victoria, Kale, Shiv, Hontecillas, Raquel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318425/ https://www.ncbi.nlm.nih.gov/pubmed/28270815 http://dx.doi.org/10.3389/fimmu.2017.00178 |
Ejemplares similares
-
Modeling the Role of Lanthionine Synthetase C-Like 2 (LANCL2) in the Modulation of Immune Responses to Helicobacter pylori Infection
por: Leber, Andrew, et al.
Publicado: (2016) -
NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host–Gut Microbiota Interactions during Inflammatory Bowel Disease
por: Leber, Andrew, et al.
Publicado: (2018) -
Nlrx1-Regulated Defense and Metabolic Responses to Aspergillus fumigatus Are Morphotype and Cell Type Specific
por: Kastelberg, Bridget, et al.
Publicado: (2021) -
Abscisic acid enriched fig extract promotes insulin sensitivity by decreasing systemic inflammation and activating LANCL2 in skeletal muscle
por: Leber, Andrew, et al.
Publicado: (2020) -
Computational Modeling-Based Discovery of Novel Classes of Anti-Inflammatory Drugs That Target Lanthionine Synthetase C-Like Protein 2
por: Lu, Pinyi, et al.
Publicado: (2012)